REQUEST A DEMO
Total
USD $0.00
Search more companies

Asia Medi Science Company Limited (Thailand)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Asia Medi Science Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Asia Medi Science Company Limited is based in Thailand. The head office is in Ubon Ratchathani. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on June 09, 2026. 20 (estimated) employees currently work for Asia Medi Science Company Limited. The company’s latest financial report indicates a net sales revenue drop of 0.97% in 2024. Its’ total assets recorded a growth of 48.36%. The net profit margin of Asia Medi Science Company Limited increased by 1.37% in 2024.

Headquarters
88/36 Moo 1 Tha Bo Tai (The River Project) Village
Ubon Ratchathani; North-Eastern Thailand; Postal Code: 34000

Contact Details: Purchase the Asia Medi Science Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Asia Medi Science Company Limited report to view the information.
Financial Auditors:
Purchase the Asia Medi Science Company Limited report to view the information.
Incorporation Date:
June 09, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Asia Medi Science Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
-0.97%
Total Operating Revenue
-0.96%
Operating Profit
126.07%
EBITDA
126.07%
Net Profit/Loss for the Period
159.05%
Total Assets
48.36%
Total Equity
15.61%
Operating Profit Margin
3.48%
Net Profit Margin
1.37%
Return on Equity (ROE)
7.47%
Debt / Equity
87.11%
Quick Ratio
0.51%
Cash Ratio
0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?